• LAST PRICE
    0.4231
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.4231/ 2
  • Ask / Lots
    0.4500/ 1
  • Open / Previous Close
    0.0000 / 0.4231
  • Day Range
    ---
  • 52 Week Range
    Low 0.3920
    High 4.6900
  • Volume
    551
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 0.4076
TimeVolumeASLN
09:32 ET43170.41
09:35 ET68880.4175
09:39 ET195100.42
09:53 ET2500.44039
09:55 ET7440.4404
09:57 ET29790.429
10:00 ET9570.43
10:04 ET1000.432
10:06 ET9000.4399
10:15 ET19750.4395
10:22 ET4890.4303
10:26 ET7000.4302
10:27 ET1000.4303
10:31 ET3000.4303
10:36 ET8440.4303
10:40 ET300330.41
10:44 ET10000.42
10:47 ET1000.425
10:51 ET9000.425
10:54 ET42000.415
10:58 ET9580.4357
11:02 ET8000.41
11:12 ET8000.41
11:20 ET8000.4102
11:25 ET1000.4102
11:27 ET41000.439
11:30 ET1000.411
11:32 ET8000.4102
11:36 ET22000.425
11:38 ET8000.425
11:41 ET7000.4103
11:45 ET4240.42
11:48 ET20000.439
11:50 ET7000.42
11:57 ET2000.4301
11:59 ET1000.4311
12:01 ET7000.4311
12:08 ET3420.4311
12:10 ET7000.4311
12:12 ET1000.4311
12:14 ET40780.43505
12:21 ET9900.4389
12:32 ET35180.43
12:35 ET12000.43
12:37 ET95570.43
12:39 ET87970.43
12:42 ET1000.4399
12:50 ET1000.4208
12:55 ET1000.43035
12:57 ET7000.4207
01:06 ET7000.4207
01:15 ET7000.4207
01:26 ET2000.4208
01:29 ET7000.42
01:31 ET1000.4305
01:38 ET7000.42
01:42 ET163000.421
01:49 ET7000.42
02:00 ET7000.42
02:07 ET1000.4202
02:09 ET2000.44
02:12 ET28000.42
02:20 ET1000.42
02:21 ET7000.42
02:32 ET8000.42
02:39 ET7000.42
02:43 ET1000.42
02:48 ET3000.42
02:50 ET7000.42
02:54 ET1000.42
02:59 ET7000.4203
03:06 ET7000.423
03:08 ET31000.4231
03:10 ET41190.4265
03:12 ET12000.423
03:14 ET6740.439
03:15 ET61000.435051
03:17 ET1140.4301
03:19 ET9000.4301
03:24 ET15000.4301
03:26 ET10000.4301
03:32 ET7000.4333
03:33 ET6000.4301
03:37 ET5000.4301
03:42 ET9340.4301
03:44 ET7000.4301
03:46 ET1000.4301
03:48 ET17060.4333
03:50 ET1000.4332
03:51 ET1000.4301
03:53 ET4000.4301
03:55 ET8000.4301
03:57 ET10670.4379
04:00 ET16530.4231
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesASLN
Aslan Pharmaceuticals Ltd
9.9M
-0.1x
---
United StatesBUDZ
Weed Inc
10.0M
-20.2x
---
United StatesHEPA
Hepion Pharmaceuticals Inc
10.2M
-0.2x
---
United StatesPHGE
Biomx Inc
9.7M
-0.3x
---
United StatesNDRA
ENDRA Life Sciences Inc
9.6M
-0.4x
---
United StatesGRTX
Galera Therapeutics Inc
10.4M
-0.1x
---
As of 2024-02-27

Company Information

ASLAN Pharmaceuticals Limited is a clinical-stage immunology focused biopharmaceutical company. The Company's portfolio is led by eblasakimab (ASLAN004), a potential human monoclonal antibody that binds to the IL-13 receptor a1 subunit (IL-13Ra1), blocking signaling of two pro-inflammatory cytokines, IL-4 and IL-13, which are central to triggering symptoms of atopic dermatitis, such as redness and itching of the skin. It is conducting a Phase II b clinical trial investigating eblasakimab as a therapeutic antibody for moderate-to-severe atopic dermatitis (AD). The Company is also developing farudodstat (ASLAN003), an orally active, potent inhibitor of human dihydroorotate dehydrogenase (DHODH) that has the potential to be a therapy for autoimmune disease. The Company is also focused on developing antagonists of the aryl hydrocarbon receptor (AhR), an immune checkpoint inhibitor, through a joint venture.

Contact Information

Headquarters
83 Clemenceau Avenue, #12-03 Ue Square, Singapore 239920
Phone
---
Fax
---

Executives

Independent Chairman of the Board
Andrew Howden
Chief Executive Officer, Director
Carl Firth
Chief Operating Officer, Head of Finance
Kiran Asarpota
General Counsel
Ben Goodger
Chief Business Officer
Stephen Doyle

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$9.9M
Revenue (TTM)
$12.0M
Shares Outstanding
939.3K
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.34
EPS
$-3.01
Book Value
$3.00
P/E Ratio
-0.1x
Price/Sales (TTM)
0.8
Price/Cash Flow (TTM)
---
Operating Margin
-369.02%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.